Skip to content
Madrigal Pharmaceuticals, Inc. Corporate Site
Contact Us
Search for:
MASH/NASH
Clinical Trials
Publications
Request Medical Information
Submit an Educational Grant Request
Investigator-Initiated Studies
Baseline characteristics in patients with well-compensated MASH cirrhosis diagnosed with or without a liver biopsy in MAESTRO-NASH- OUTCOMES, a clinical outcome phase 3 study assessing the effect of resmetirom in well-compensated NASH cirrhosis
Poster Presentation
File size: 1.62 MB
Created: 06-05-2025
Updated: 07-05-2025
Hits: 13
Download
Preview
Page load link
Go to Top